Loxo Oncology Inc (LOXO): Deerfield Management Discloses 13.65% Activist Stake

Samuel Isaly‘s Orbimed Advisors has disclosed holding a stake in Loxo Oncology Inc (NASDAQ:LOXO). The fund reported buying 275,385 shares in an open-market transaction, at a price of $13 apiece, while another 1.90 million shares have been obtained through the conversion of Series A convertible preferred stock. In this way, Orbimed currently holds around 2.18 million shares of Loxo Oncology Inc (NASDAQ:LOXO), the activist stake amassing 13.65% of the company’s common stock.

Loxo Oncology

Orbimed Advisors also was one of the investors of the company before it went public, being mentioned among the principal stockholders, in Loxo Oncology’s S-1 filing with the SEC. Loxo Oncology Inc (NASDAQ:LOXO) is a small cap healthcare company, engaged in the development of small molecule therapeutics for targeted treatment of cancer. The company went public at the beginning of the month. James Flynn‘s Deerfield Management has also reported a stake in Loxo Oncology Inc (NASDAQ:LOXO), disclosing ownership of 1.59 million shares, its passive stake being equal to almost 10% of the company’s outstanding stock.

Disclosure: none

Biotech Insider Alert - $5 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!